LONDON, September 26, 2023 – The Polish-British Future of Healthcare Event, focusing on advancements in MedTech, BioTech, and scientific research, will soon take place at the Royal Society of Medicine. SyVento BioTech will be represented by Tomasz Piec, Chairman of the Supervisory Board, and Dominik Lipka, our CTO.
International Cooperation in BioTech: A Business Imperative
In the rapidly changing global biotech landscape, international collaboration has become essential. Shared knowledge, resources, and research across countries have led to significant progress in drug development, medical devices, and genetic research. For Poland, increased international partnerships in the BioTech sector can lead to both economic growth and advancement in research.
SyVento BioTech’s Approach to Global Collaboration
SyVento BioTech places a high emphasis on international partnerships, as demonstrated by our recent collaborations with UK entities. Our Research and Development centre is equipped with the latest technology, and our dedicated R&D Team is focused on integrating global insights with our core research capacities.
Our R&D team’s efforts to collaborate on a global scale have yielded productive outcomes and fostered meaningful international relationships.
Event Details and Networking Opportunities
The upcoming event at the Royal Society of Medicine on September 29th is organized by several notable entities, including the Embassy of the Republic of Poland in London, Polish Investment and Trade Agency (PAIH), and the Medical Research Agency. The event will feature keynotes from industry leaders such as Radosław Sierpiński and Professor Zosia Miedzybrodzka. Attendees will have the opportunity to network with representatives from various biotech and medtech companies from Poland.
As biotech industries worldwide navigate contemporary challenges and opportunities, international collaboration remains a key strategy for growth and innovation. SyVento BioTech continues to prioritize global partnerships and research initiatives in its mission.